Rheumatoid arthritis drugs Remicade, Enbrel, Humira, and Cimzia have been linked to a possibly fatal fungal infection.  The FDA has issued an order requiring a black box warning label for the risk of histoplasmosis.  Histoplasmosis, a fungal infection with flu-like sysmptoms, can spread beyond the respiratory system and attack other internal organs.  240 cases have been reported, with a fatality rate of around 20%.

Remicade, Enbrel, Humira, and Cimzia are all drugs classified as tumor necrosis factor alpha blockers designed to treat rheumatoid arthritis and other serious diseases.  Remicade (infliximab) is manufactured by Centocor (Johnson & Johnson).  Enbrel (etanercept) is manufactured by Amgen and Wyeth.  Humira (adalimumab) is manufactured by Abbott Laboratories.  Cimzia (certolizumab pegol) is manufactured by UCB.


We Can Help

If you or a loved one has been diagnosed with histoplasmosis or has been hospitalized while taking any tumor necrosis factor alpha blocker such as Remicade, Enbrel, Cimzia or Humira, contact The Law Offices of Larry H. Parker.  We are proud to be partnered with a nationally recognized team of product liability attorneys focused on obtaining the maximum recovery possible.  Our team of pharmaceutical attorneys is ready to fight for you!

For a free, confidential, no-obligation consultation, please fill out a form or give us a call at (800) 333-0000.  Your call or email will only be handled by caring, understanding, and experienced case evaluators.  Your confidentiality is guaranteed! Nobody will fight harder for you.  Nobody.

* Please be advised that no attorney/client relationship will be established by website visit or submission to larryhparker.com™. An attorney/client relationship can only begin when a retainer has been signed.